Europe Video

European shares took a breather on Wednesday following a strong finish on Wall Street Tuesday where the S&P 500 crossed 1,900 points for the first time.

Robert Wood, chief U.K. economist at Berenberg, and Chris Watling, CEO of Longview Economics, discuss how inflation influences the Bank of England's decision to raise interest rates.

Roland Vogel, CFO of Hannover Re, says the company likes higher interest rates and can react to moves in the rate.

Chris Grigg, CEO of British Land, says a supply shortage is likely to push London office rents higher which will help the company.

Philip Borel, editorial director at PEI, says private equity funding is strong outside of the U.S.

Dieter Wemmer, CFO at Allianz, says he is not concerned about the outflows from Pimco and commends Bill Gross on his "professionalism".

Bond rally 'irresistible': Pro     Wed, 14 May '14 | 1:45 AM ET

Peter Chatwell, interest rate strategist at Credit Agricole CIB, says investors need to buy bonds in the current environment.

British members of parliament talk to CNBC about their skepticism surrounding Pfizer's takeover bid for AstraZeneca after the U.S. drug company's boss was grilled by lawmakers.

Andy Soper, global head of G10 options flow at Nomura, says shorting the euro is starting to become and interesting trade.

Jenny Dawson, founder of Rubies in the Rubble, and winner of the Veuve Cliquot new generation award, explains that her company is a luxury food brand that aims to raise awareness about global food imbalances.

Time to get back into EM?     Tue, 13 May '14 | 11:35 AM ET

Maarten-Jan Bakkum, global emerging markets strategist at ING Investment Management, says emerging markets have recovered a bit, due to "political excitement" and expectations of improved liquidity.

'Momentum trade' in European bonds     Tue, 13 May '14 | 11:20 AM ET

Didier Duret, global CIO of ABN Amro Private Banking, and Louis Gargour, CIO of LNG Capital, discuss how deflation fears have created a momentum trade in European government bonds.

European market closes higher     Tue, 13 May '14 | 11:30 AM ET

European bourses closed higher on Tuesday, as investors mulled whether new measures by the European Central Bank could soon be announced.

Pascal Soriot, AstraZeneca CEO, says the group has what it takes to succeed on its own and that its "stand-alone strategy" will create value for its shareholders.

AstraZeneca has the "critical mass" to succeed internationally, Pascal Soriot, CEO of AstraZeneca told CNBC, also discussing the group¿s pipeline.

Gerhard Roiss, CEO of OMV, discusses the impact of the Russian sanctions on European gas, and dismisses calls for a unified gas price across the region.

Scott Moeller, director of the M&A research centre at Cass Business School, discusses the potential AstraZeneca takeover and Pfizer's strategy.

Jason Kolbert, head of health care equity research at Maxim Group, says Pfizer's takeover bid is driven by AstraZeneca's pipeline, strategic tax advantages and cost savings.

Ian Read, CEO of Pfizer, says there is a "very strong industrial rationale" behind its AstraZeneca's takeover bid, as the groups' pipelines would both benefit from being combined.

Why you should favour large-caps     Tue, 13 May '14 | 5:30 AM ET

Andrew Burkly, head of institutional portfolio strategy at Oppenheimer & Co., says the underlying fundamentals for U.S. equities remain "pretty constructive", and large cap stocks should outperform small caps this year.

'Brand EU' not strong enough: Expert     Tue, 13 May '14 | 4:40 AM ET

Nicolas De Santis, president and secretary general at Gold Mercury International, says the European Union has an "identity problem" and needs a stronger brand and identity.

Christian Keller, head of emerging markets research at Barclays, says emerging market credit valuation is quite attractive but advises being "choosy and picky."

Robots and flatpacks: The future of construction

Chuka Umunna, U.K. shadow business secretary, says Labour is advocating the introduction of a new "public interest control" category to relate to U.K. science and R&D.

Chuka Umunna, U.K. shadow business secretary, says the potential AstraZeneca takeover by Pfizer should be looked at as of national economic interest, and that more should be done to protect R&D jobs.

Ranjith Gopinathan, program manager for life sciences and health care practice at Frost & Sullivan, explains why he believes the Pfizer/AstraZeneca deal would be positive.

Tony Burke, assistant general secretary of Unite, says Pfizer's promises to keep jobs in and research in the U.K. are "not worth the paper they are written on".

Paul Donovan, global economist at UBS, discusses the U.K.'s real estate market and whether the soaring house prices in London are sustainable.

Frederic Oudea, CEO of Société Générale, says the Ukraine crisis has led to a slowdown in the Russian economy, but the bank confirms its commitment to the country.

Howard Silverblatt, senior index analyst at S&P Dow Jones Indices, says U.S. corporates are being "stingy" with their dividend payouts despite sitting on large cash piles.

Contact Europe Video


    Get the best of CNBC in your inbox

    › Learn More